| 今开：0.0 | 昨收：0.0 |
| 最高：0.0 | 最低：0.0 |
| 涨停价：0.0 | 跌停价：0.0 |
| 总市值：5.52493E7 |
药渡2018-01-30 21:38
为贯彻落实中共中央办公厅、国务院办公厅《关于深化审评审批制度改革鼓励药品医疗器械创新的意见》（厅字﹝2017﹞42号）的要求，引导仿制药研发生产，提高公众用药可及性，我中心筛选出依鲁司他等9个国内化合物专利权到期、终止、无效且尚无仿制申请的国外已上市且具有明确临床价值的药品，现纳入...查看全文
深思远见2015-07-12 22:39
$Aegerion制药(AEGR)$近期评级信息如下：
20150706 Guggenheim Securities 降级， 评级：中性->卖出，
更多分析和资讯，请关注微-信-公-众-号 stock_tong查看全文
$Aegerion制药(AEGR)$ SC 13D - General statement of acquisition of beneficial ownership Filed: 2016-06-22 AccNo: 0000919574-16-013770 Size: 94 KB 网页链接
$Aegerion制药(AEGR)$ 425 - Prospectuses and communications, business combinations Filed: 2016-06-16 AccNo: 0001104659-16-127785 Size: 50 KB 网页链接
$Aegerion制药(AEGR)$ 425 - Prospectuses and communications, business combinations Filed: 2016-06-16 AccNo: 0001104659-16-127777 Size: 26 KB 网页链接
$Aegerion制药(AEGR)$ 425 - Prospectuses and communications, business combinations Filed: 2016-06-16 AccNo: 0001104659-16-127587 Size: 623 KB 网页链接
$Aegerion制药(AEGR)$ 425 - Prospectuses and communications, business combinations Filed: 2016-06-16 AccNo: 0001104659-16-127434 Size: 1 MB 网页链接
$Aegerion制药(AEGR)$ SC 13D/A [Amend] - General statement of acquisition of beneficial ownership Filed: 2016-06-16 AccNo: 0000899140-16-001496 Size: 178 KB 网页链接
$Aegerion制药(AEGR)$ 425 - Prospectuses and communications, business combinations Filed: 2016-06-15 AccNo: 0001104659-16-127408 Size: 1 MB 网页链接
$Aegerion制药(AEGR)$ 425 - Prospectuses and communications, business combinations Filed: 2016-06-15 AccNo: 0001104659-16-127405 Size: 105 KB 网页链接
$Aegerion制药(AEGR)$ 425 - Prospectuses and communications, business combinations Filed: 2016-06-15 AccNo: 0001104659-16-127354 Size: 2 MB 网页链接
$Aegerion制药(AEGR)$ 8-K - Current report Filed: 2016-06-15 AccNo: 0001104659-16-127353 Size: 2 MBItem 1.01: Entry into a Material Definitive AgreementItem 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a RegistrantI...